Literature DB >> 17955264

Cellular oxygen sensing in health and disease.

David R Mole1, Peter J Ratcliffe.   

Abstract

To avoid localised problems resulting from excess or inadequate oxygen, all cells and tissues have the ability to sense and respond to changes in oxygen levels. Despite their rich blood supply, the kidneys have unique properties with respect to oxygen that enable them to act as specialised organs, sensing oxygen delivery as well as rendering them prone to hypoxic injury. Essential to normal growth and development, as well as the control of energy metabolism, angiogenesis and erythropoiesis, cellular oxygen homoeostasis is central to the pathophysiology of anaemia, ischaemia, inflammation and cancer, both within the kidney and more generally. A major transcriptional pathway, predominantly regulated by hypoxia-inducible factor (HIF), controls many hundreds of genes, either directly or indirectly, that serve to modulate both the supply and consumption of oxygen. Recent advances have illuminated the mechanisms underlying the regulation of HIF by oxygen and have defined novel therapeutic targets. The challenge now is for us to understand the complexities generated by multiple isoforms of the various components of oxygen sensing, the identification of additional levels of control, and the tissue specific responses to activation of the HIF pathway.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17955264     DOI: 10.1007/s00467-007-0632-x

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  127 in total

1.  The number and distribution of capillaries in muscles with calculations of the oxygen pressure head necessary for supplying the tissue.

Authors:  A Krogh
Journal:  J Physiol       Date:  1919-05-20       Impact factor: 5.182

2.  Hypoxia-inducible factor 1-alpha reduces infarction and attenuates progression of cardiac dysfunction after myocardial infarction in the mouse.

Authors:  Masakuni Kido; Lingling Du; Christopher C Sullivan; Xiaodong Li; Reena Deutsch; Stuart W Jamieson; Patricia A Thistlethwaite
Journal:  J Am Coll Cardiol       Date:  2005-11-09       Impact factor: 24.094

Review 3.  Role of fibroblast growth factor receptor signaling in kidney development.

Authors:  Carlton M Bates
Journal:  Pediatr Nephrol       Date:  2006-08-24       Impact factor: 3.714

4.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.

Authors:  P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

5.  Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Authors:  P Jaakkola; D R Mole; Y M Tian; M I Wilson; J Gielbert; S J Gaskell; A von Kriegsheim; H F Hebestreit; M Mukherji; C J Schofield; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

6.  An essential role for p300/CBP in the cellular response to hypoxia.

Authors:  Z Arany; L E Huang; R Eckner; S Bhattacharya; C Jiang; M A Goldberg; H F Bunn; D M Livingston
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

7.  von Hippel-Lindau protein binds hyperphosphorylated large subunit of RNA polymerase II through a proline hydroxylation motif and targets it for ubiquitination.

Authors:  Anna V Kuznetsova; Jaroslaw Meller; Phillip O Schnell; James A Nash; Monika L Ignacak; Yolanda Sanchez; Joan W Conaway; Ronald C Conaway; Maria F Czyzyk-Krzeska
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-25       Impact factor: 11.205

8.  Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma.

Authors:  Sakari Vanharanta; Mary Buchta; Sarah R McWhinney; Sanna K Virta; Mariola Peçzkowska; Carl D Morrison; Rainer Lehtonen; Andrzej Januszewicz; Heikki Järvinen; Matti Juhola; Jukka-Pekka Mecklin; Eero Pukkala; Riitta Herva; Maija Kiuru; Nina N Nupponen; Lauri A Aaltonen; Hartmut P H Neumann; Charis Eng
Journal:  Am J Hum Genet       Date:  2003-12-18       Impact factor: 11.025

9.  Iron-mediated degradation of IRP2, an unexpected pathway involving a 2-oxoglutarate-dependent oxygenase activity.

Authors:  Jian Wang; Guohua Chen; Martina Muckenthaler; Bruno Galy; Matthias W Hentze; Kostas Pantopoulos
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

10.  Posttranslational hydroxylation of ankyrin repeats in IkappaB proteins by the hypoxia-inducible factor (HIF) asparaginyl hydroxylase, factor inhibiting HIF (FIH).

Authors:  Matthew E Cockman; David E Lancaster; Ineke P Stolze; Kirsty S Hewitson; Michael A McDonough; Mathew L Coleman; Charlotte H Coles; Xiaohong Yu; Ronald T Hay; Steven C Ley; Christopher W Pugh; Neil J Oldham; Norma Masson; Christopher J Schofield; Peter J Ratcliffe
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-26       Impact factor: 11.205

View more
  21 in total

1.  Deletion of von Hippel-Lindau in glomerular podocytes results in glomerular basement membrane thickening, ectopic subepithelial deposition of collagen {alpha}1{alpha}2{alpha}1(IV), expression of neuroglobin, and proteinuria.

Authors:  Brooke M Steenhard; Kathryn Isom; Larysa Stroganova; Patricia L St John; Adrian Zelenchuk; Paul B Freeburg; Lawrence B Holzman; Dale R Abrahamson
Journal:  Am J Pathol       Date:  2010-06-03       Impact factor: 4.307

2.  Decreased VEGF expression and microvascular density, but increased HIF-1 and 2α accumulation and EPO expression in chronic moderate hyperoxia in the mouse brain.

Authors:  Girriso F Benderro; Xiaoyan Sun; Youzhi Kuang; Joseph C Lamanna
Journal:  Brain Res       Date:  2012-07-20       Impact factor: 3.252

Review 3.  The future of toxicity testing: a focus on in vitro methods using a quantitative high-throughput screening platform.

Authors:  Sunita J Shukla; Ruili Huang; Christopher P Austin; Menghang Xia
Journal:  Drug Discov Today       Date:  2010-08-11       Impact factor: 7.851

4.  Hyperoxaluria-induced tubular ischemia: the effect of verapamil on the limitation of tissue HIF-1 alpha levels in renal parenchyma.

Authors:  Faruk Yencilek; Kemal Sarica; Bilal Eryildirim; Sakip Erturhan; Metin Karakok; Ugur Kuyumcuoglu
Journal:  Int Urol Nephrol       Date:  2009-07-16       Impact factor: 2.370

5.  CoCl2-induced biochemical hypoxia down regulates activities and expression of super oxide dismutase and catalase in cerebral cortex of mice.

Authors:  Anupama Rani; S Prasad
Journal:  Neurochem Res       Date:  2014-07-23       Impact factor: 3.996

6.  Identification of chemical compounds that induce HIF-1alpha activity.

Authors:  Menghang Xia; Ruili Huang; Yi Sun; Gregg L Semenza; Shelley Force Aldred; Kristine L Witt; James Inglese; Raymond R Tice; Christopher P Austin
Journal:  Toxicol Sci       Date:  2009-06-05       Impact factor: 4.849

7.  Cobalt treatment does not prevent glomerular morphological alterations in type 1 diabetic rats.

Authors:  Gaaminepreet Singh; Pawan Krishan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-06-02       Impact factor: 3.000

8.  Identification of small molecule compounds that inhibit the HIF-1 signaling pathway.

Authors:  Menghang Xia; Kun Bi; Ruili Huang; Ming-Hsuang Cho; Srilatha Sakamuru; Susanne C Miller; Hua Li; Yi Sun; John Printen; Christopher P Austin; James Inglese
Journal:  Mol Cancer       Date:  2009-12-09       Impact factor: 27.401

9.  Renal expression of hypoxia inducible factor-1α in patients with chronic kidney disease: a clinicopathologic study from nephrectomized kidneys.

Authors:  Tung-Wei Hung; Jia-Hung Liou; Kun-Tu Yeh; Jen-Pi Tsai; Sheng-Wen Wu; Hui-Chun Tai; Wei-Tse Kao; Shu-Hui Lin; Ya-Wen Cheng; Horng-Rong Chang
Journal:  Indian J Med Res       Date:  2013-01       Impact factor: 2.375

10.  MicroRNA 107 partly inhibits endothelial progenitor cells differentiation via HIF-1β.

Authors:  Shu Meng; JiaTian Cao; LianSheng Wang; Qing Zhou; YiGang Li; ChengXing Shen; XiaoPing Zhang; ChangQian Wang
Journal:  PLoS One       Date:  2012-07-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.